tert-butyl 2-(3-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetate

Catalog No. :
ACSJVU171
CAS No. :
-
Molecular Formula :
C29H30N4O7
Molecular Weight :
546.58

IUPAC Name:tert-butyl 2-(3-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetate

tert-butyl 2-(3-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$350.00Login to see priceInquiryInquiry
250mg95%$700.00Login to see priceInquiryInquiry
1g95%$1323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-butyl 2-(3-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetate
IUPAC Nametert-butyl 2-(3-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetate
Molecular FormulaC29H30N4O7
Molecular Weight546.58
SMILESCC(C)(C)OC(=O)CN1C(=O)C(NC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCC2=CC=CC=C21
InChI KeySMJWSNODKGFOGY-UHFFFAOYSA-N

Synthetic Route by SureRoute

1. ACSJVU171 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTUEL831 route compound structure diagram
    ACTUEL83198626-45-0 In Stock
  2. Plus
  3. ACYCKQ570 route compound structure diagram
    ACYCKQ5702093536-12-8 In Stock
  4. Then
  5. ACSJVU171 route product structure diagram
    ACSJVU171-
Inquiry

2. ACSJVU171 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMFGQ641 route compound structure diagram
    ACMFGQ64119171-19-8 In Stock
  4. Then
  5. ACSJVU171 route product structure diagram
    ACSJVU171-
Inquiry

Comments (0)